SCLC-N | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,414 results for “SCLC-N”

Trials

View all 7538 →

The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy

55 participants · First posted Mar 13, 2013

N/A (N/A)

70 participants

N/A (N/A)

111 participants

Drugs

View all 2190 →

DLL3xCD3 bispecific antibody (SCLC/NET)

Bicine

C₆H₁₃NO₄

N,N,N-trimethylglycinium

C₅H₁₂NO₂

Organizations

View all 86 →

N&N Pharmaceuticals, Inc.

United States

n-Lorem Foundation

United States

Allen N Wilkins MD

United States

News

View all 2600 →

Small Cell Lung Cancer Subtypes Identified, Paving Way for Personalized Treatment

Whitehawk Therapeutics Validates SEZ6 as High-Expression Target for Small Cell Lung Cancer ADC Development

SNB-101 Receives FDA Fast Track Designation for Small Cell Lung Cancer

Page 1 of 1242